title: [Effective evaluation of liver transplantation for hepatocellular carcinoma].
abstract: OBJECTIVE
  To evaluate the effect of liver transplantation for hepatocellular carcinoma and to explore the suitable indication for liver transplantation for advanced primary hepatocellular carcinoma.
  
  
  METHODS
  Clinical data were collected and studied with 43 patients with cirrhosis who had unresectable hepatocellular carcinoma and who underwent liver transplantation from August, 2000 to December, 2003. All the survived patients were followed up.
  
  
  RESULTS
  The longest following period was 45 months. 18 patients died by the end of the April, 2004. The 1-year survival rate was 85.5%, the 2-year survival rate 65.5%, the 3-year survival rate was 43.0%.
  
  
  CONCLUSIONS
  In our country, some advanced primary hepatocellular carcinoma without extrahepatic metastasis is still indicated for liver transplantation. Some patients could have the opportunity to survive relatively long time.
authors.affiliation: Department of General Surgery, The Third Hospital of Peking University, Beijing 100083, China.
authors.forename: Shi-Bing
authors.initials: SB
authors.lastname: Song
authors.forename: Tong-Lin
authors.initials: TL
authors.lastname: Zhang
authors.forename: Dian-Rong
authors.initials: DR
authors.lastname: Xiu
authors.forename: Jiong
authors.initials: J
authors.lastname: Yuan
authors.forename: De-Chen
authors.initials: DC
authors.lastname: Wang
authors.forename: Bin
authors.initials: B
authors.lastname: Jiang
authors.forename: Chang-Ming
authors.initials: CM
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D015996:Survival Rate